In Search of the Appropriate Anticoagulant-Associated Bleeding Risk Assessment Model for Cancer-Associated Thrombosis Patients

SIMPLE SUMMARY: Patients with venous thromboembolism events in the context of cancer should receive anticoagulants as long as the cancer is active. Therefore, a tailor-made anticoagulation strategy should rely on an individualized assessment of the risks of recurrent venous thromboembolism and antic...

Descripción completa

Detalles Bibliográficos
Autores principales: Poénou, Géraldine, Tolédano, Emmanuel, Helfer, Hélène, Plaisance, Ludovic, Happe, Florent, Versini, Edouard, Diab, Nevine, Djennaoui, Sadji, Mahé, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029420/
https://www.ncbi.nlm.nih.gov/pubmed/35454844
http://dx.doi.org/10.3390/cancers14081937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029420/
https://www.ncbi.nlm.nih.gov/pubmed/35454844
http://dx.doi.org/10.3390/cancers14081937

Ejemplares similares